The Society of Hospital Pharmacists of Australia has announced its first tranche of provisionally accredited residency program sites.
SHPA Chief Executive Kristin Michaels says 23 residency program sites have been accredited across Australia.
“In mid-October, we announced that 32 applications for accreditation had been received covering 57 hospitals, with a likely intake of over 130 residents,” Michaels says.
“SHPA has now undertaken a detailed review of all residency program applications and evaluated them against the SHPA Accreditation Standards for pharmacy residency programs.
“That 72% have been awarded Accreditation following this evaluation reflects the quality of practice in hospital pharmacies around Australia and their continued commitment to experiential learning and training.
“It was evident that all applicants had dedicated substantial time not only to preparing their comprehensive applications, but in planning their site-specific residency programs,” says Michaels.
The small number of remaining sites that have not yet been accredited have been asked to submit additional information or to clarify some responses.
“We look forward to making another announcement about additional sites achieving accreditation in the coming weeks,” says Michaels.
“Across all applications, there were many excellent examples of innovative experiential learning ideas, and sound evidence of detailed structures already in place with many skilled staff ready to coordinate and support a future residency program.”
SHPA’s Residency Program is a structured, formalised, supported and accredited national program of practice based experiential training. It is a two-year program that will begin in 2017.